# Balanced Placebo Design With Varenicline: Pharmacological and Expectancy Effects on Medication Adherence

> **NCT03538808** · PHASE4 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 80 (actual)

## Conditions studied

- Medication Adherence

## Interventions

- **DRUG:** Varenicline
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03538808
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-06
- **Primary completion:** 2019-10-29
- **Final completion:** 2019-10-29
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2020-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03538808

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03538808, "Balanced Placebo Design With Varenicline: Pharmacological and Expectancy Effects on Medication Adherence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03538808. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*